Sort
85,873 grants matching “alzheimers”
New Approaches to Dementia Heterogeneity
$1,254,932University Of California San Francisco · P50 · FY2004 · AG
Novel Approaches for Tau PROTAC Drug Discovery
$1,254,536Karteek Kadimisetty · Lifesensors, Inc. · R44 · FY2023 · AG
Novel platform for research brain banking and characterization using integrated traditional and quantitative analyses to promote precision neuropathology of Alzheimer's disease
$1,254,307Christopher D Keene · Allen Institute · U19 · FY2023 · AG
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,253,887Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND
$1,253,815Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2017 · AG
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$1,253,643Joaquin M. Espinosa · University Of Colorado Denver · R33 · FY2024 · HD
3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development
$1,253,527Layla Ghaffari · Synapticure, Inc. · R44 · FY2025 · NS
Chaperome networks in Alzheimer's disease
$1,253,488Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG
Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimer's Disease-Related Neuropathology
$1,253,356Elaine R. Peskind · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · NS
National Center for Advanced ESR Technology
$1,253,355Jack H Freed · Cornell University · P41 · FY2014 · GM
Connectomic imaging in familial and sporadic frontotemporal degeneration
$1,253,197Murray Grossman · University Of Pennsylvania · U01 · FY2016 · AG
Reducing Disparities in Dementia and VCID Outcomes in a Multicultural Rural Population
$1,253,021James E Galvin · University Of Miami School Of Medicine · R01 · FY2020 · NS
Multi-Modality Image Data Fusion and Machine Learning Approaches for Personalized Diagnostics and Prognostics of MCI due to AD
$1,252,970Fleming Y. M. Lure · Ms Technologies Corporation · R42 · FY2020 · AG
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,252,899Robert J Gropler · Washington University · P41 · FY2022 · EB
Interrogation of a human microglia phenotype associated with Alzheimer's disease
$1,252,831Marta Olah · Columbia University Health Sciences · RF1 · FY2021 · AG
Health Promotion and Disease Prevention Research Centers
$1,252,801Scott C Carvajal · University Of Arizona · U48 · FY2023 · DP
Imaging and Analysis Techniques to Construct a Cell Census Atlas of the Human Brain
$1,252,605Bruce Fischl · Massachusetts General Hospital · U01 · FY2019 · MH
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
$1,252,101Arkadij Elizarov · Trace-Ability, Inc. · R44 · FY2022 · AG
CNS DEGENERATION CAUSED BY NOVEL PATHOGENS
$1,252,039University Of California San Francisco · P50 · FY2000 · NS
Development of a Remotely Deliverable Cognitive Assessment Sensitive to Early Stage Mild Cognitive Impairment.
$1,251,954Peter Kallestrup · I-Function, Inc. · R44 · FY2022 · AG
National Center for Quantitative Biology of Complex Systems
$1,251,614Joshua J Coon · University Of Wisconsin-Madison · P41 · FY2024 · GM
National Center for Quantitative Biology of Complex Systems
$1,251,614Joshua J Coon · University Of Wisconsin-Madison · P41 · FY2025 · GM
National Center for Quantitative Biology of Complex Systems
$1,251,614Joshua J Coon · University Of Wisconsin-Madison · P41 · FY2022 · GM
National Center for Quantitative Biology of Complex Systems
$1,251,614Joshua J Coon · University Of Wisconsin-Madison · P41 · FY2023 · GM
Signaling in the retina and retinal pigment epithelium
$1,251,584Thomas Redmond · National Eye Institute · ZIA · FY2018 · EY